AAAAAA
Results:
1-16
|
Results: 16
Authors:
Gullick, WJ
Citation: Wj. Gullick, The Type 1 growth factor receptors and their ligands considered as a complex system, ENDOCR-R CA, 8(2), 2001, pp. 75-82
Authors:
Raj, EH
Skinner, A
Mahji, U
Nirmala, KN
Ravichandran, K
Shanta, V
Hurst, HC
Gullick, WJ
Rajkumar, T
Citation: Eh. Raj et al., Neuregulin 1-alpha expression in locally advanced breast cancer, BREAST, 10(1), 2001, pp. 41-45
Authors:
Srinivasan, R
Leverton, KE
Sheldon, H
Hurst, HC
Sarraf, C
Gullick, WJ
Citation: R. Srinivasan et al., Intracellular expression of the truncated extracellular domain of c-erbB-3/HER3, CELL SIGNAL, 13(5), 2001, pp. 321-330
Authors:
Gilmour, LMR
Macleod, KG
McCaig, A
Gullick, WJ
Smyth, JF
Langdon, SP
Citation: Lmr. Gilmour et al., Expression of erbB-4/HER-4 growth factor receptor isoforms in ovarian cancer, CANCER RES, 61(5), 2001, pp. 2169-2176
Authors:
Clarke, K
Smith, K
Gullick, WJ
Harris, AL
Citation: K. Clarke et al., Mutant epidermal growth factor receptor enhances induction of vascular endothelial growth factor by hypoxia and insulin-like growth factor-1 via a PI3 kinase dependent pathway, BR J CANC, 84(10), 2001, pp. 1322-1329
Authors:
Dowsett, M
Cooke, T
Ellis, I
Gullick, WJ
Gusterson, B
Mallon, E
Walker, R
Citation: M. Dowsett et al., Assessment of HER2 status in breast cancer: why, when and how?, EUR J CANC, 36(2), 2000, pp. 170-176
Authors:
Srinivasan, R
Gillett, CE
Barnes, DM
Gullick, WJ
Citation: R. Srinivasan et al., Nuclear expression of the c-erbB-4/HER-4 growth factor receptor in invasive breast cancers, CANCER RES, 60(6), 2000, pp. 1483-1487
Authors:
Kew, TY
Bell, JA
Pinder, SE
Denley, H
Srinivasan, R
Gullick, WJ
Nicholson, RI
Blamey, RW
Ellis, IO
Citation: Ty. Kew et al., c-erbB-4 protein expression in human breast cancer, BR J CANC, 82(6), 2000, pp. 1163-1170
Authors:
Leverton, KE
Gullick, WJ
Citation: Ke. Leverton et Wj. Gullick, Type I family growth factor receptors and their ligands in prostate cancer, CONT ENDOC, 2000, pp. 277-291
Authors:
Srinivasan, R
Benton, E
McCormick, F
Thomas, H
Gullick, WJ
Citation: R. Srinivasan et al., Expression of the c-erbB-3/HER-3 and c-erbB-4/HER-4 growth factor receptors and their ligands, neuregulin-1 alpha, neuregulin-1 beta, and betacellulin, in normal endometrium and endometrial cancer, CLIN CANC R, 5(10), 1999, pp. 2877-2883
Authors:
De Angelis, E
Grassi, M
Gullick, WJ
Johnson, GR
Rossi, GB
Tempesta, A
De Angelis, F
De Luca, A
Salomon, DS
Normanno, N
Citation: E. De Angelis et al., Expression of cripto and amphiregulin in colon mucosa from high risk coloncancer families, INT J ONCOL, 14(3), 1999, pp. 437-440
Authors:
Gullick, WJ
Lewanski, C
Citation: Wj. Gullick et C. Lewanski, Coronary angioplasty: an end to early closing?, GENE THER, 6(6), 1999, pp. 954-955
Authors:
Morley, GM
Uden, M
Gullick, WJ
Dibb, NJ
Citation: Gm. Morley et al., Cell specific transformation by c-fms activating loop mutations is attributable to constitutive receptor degradation, ONCOGENE, 18(20), 1999, pp. 3076-3084
Authors:
Tada, H
Sasada, R
Kawaguchi, Y
Kojima, I
Gullick, WJ
Salomon, DS
Igarashi, K
Seno, M
Yamada, H
Citation: H. Tada et al., Processing and juxtacrine activity of membrane-anchored betacellulin, J CELL BIOC, 72(3), 1999, pp. 423-434
Authors:
Gillham, H
Golding, MCHM
Pepperkok, R
Gullick, WJ
Citation: H. Gillham et al., Intracellular movement of green fluorescent protein-tagged phosphatidylinositol 3-kinase in response to growth factor receptor signaling, J CELL BIOL, 146(4), 1999, pp. 869-880
Authors:
Gullick, WJ
Srinivasan, R
Citation: Wj. Gullick et R. Srinivasan, The type 1 growth factor receptor family: new ligands and receptors and their role in breast cancer, BREAST CANC, 52(1-3), 1998, pp. 43-53
Risultati:
1-16
|